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Variation in the mechanisms that mediate antigen processing, MHC-loading, and presenta-
tion of peptides allows cells to significantly modulate the repertoire of peptides presented
by both MHC class I or class II. To more quickly determine how these different modes or
modulations of presentation translate into altered immune responses, higher throughput
methods for identifyingT cell epitopes are needed. Proteomics-based comprehensive cat-
aloging of peptides eluted from MHC is a challenging but ideal way of identifying peptide
sequences influenced by variable modes of processing and presentation. Several groups
have already been successful with this approach and ongoing technical improvements will
broaden its applicability. Subsequently, high content combinatorial peptide-MHC tetramer
staining using mass cytometry, as we have recently described, should enable the broad
assessment of how these changes are perceived by T cells and translated into an altered
immune response. The importance of this analysis is highlighted by evidence that physio-
logically relevant variation in antigen processing and presentation as well as other factors
can give rise to unpredictably different T cell responses.
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VARIATION IN ANTIGEN PROCESSING AND PRESENTATION
Antigen processing and presentation is centrally important for
T cell mediated adaptive immunity. Accordingly, the modes and
mechanisms of peptide processing and presentation by MHC class
I and class II molecules have been extensively studied and nicely
described (1). Through these studies, numerous and diverse path-
ways have been identified for both MHC class I and class II. In both
cases, the source of antigen can be exogenous, acquired through
various endocytic pathways, or endogenous, synthesized, and
processed by the antigen-presenting cell (APC) itself [reviewed
in Ref. (2, 3)]. Far from simple, the molecular players involved in
each of these pathways can also vary, allowing the APC to further
modulate the repertoire of peptides being presented. For instance,
in the case of MHC class I peptide loading, the subunit compo-
sition of the proteasome is an important factor. In addition to
the constitutive proteasome, an altered subunit composition has
been defined for both the immunoproteasome, induced by inflam-
matory signals (4), as well as the thymoproteasome, expressed by
thymic cortical epithelial cells and specialized in providing pep-
tides for T cell positive-selection (5). For MHC class II, in addition
to variation in routes of processing, which include various forms
of endocytosis and autophagocytosis (6), variable expression, and
activities of lysosomal proteases such as the cathepsins can sig-
nificantly modulate of the repertoire of epitopes presented by
differing cell types under differing conditions (7). Peptide edit-
ing by HLA-DM, which appears to facilitate preferential loading
of high-affinity MHC class II binding peptides, and the HLA-DM-
inhibitory effects of HLA-DO on this process have also been well
studied. Although exactly how HLA-DO influences the MHC class
II binding peptide repertoire is still not completely clear, its role
as an HLA-DM-competitor appears to be important for modula-
tion of antigen presentation MHC class II in the thymus and in B
lymphocytes (8–10). These examples represent only the tip of the
iceberg in modulators of peptide processing and presentation for
both MHC class I and class II. Diversity in antigen processing may
be important for modulation of the resulting immune response
as well providing alternatives for mechanisms evaded by the wide
range of strategies employed by pathogens.
For a number of pathways alluded to above, including the exam-
ple highlighting the importance of the thymoproteasome, several
studies have demonstrated the consequences of distinct antigen
processing and presentation pathways on the T cell response.
Another dramatic example of alternate processing and its effects
on the T cell mediated immune response was originally described
by Unanue and colleagues for alternate processing pathways of
the hen egg lysozyme (HEL) model antigen. In this system, some
T cells react only with APCs loaded with free exogenous peptide
(Type B antigens), while others, Type A antigen-specific T cells,
can also react with antigen derived from endogenous processing
of intact protein [reviewed in Ref. (11)]. This type of alterna-
tive antigen processing has now been shown to be involved in the
generation of insulin-reactive T cells in diabetic mice (12, 13). Fur-
thermore, in response to Influenza infection, evidence is emerging
that several pathways can be used and that the classical pathways
are not always the most important (2). Based on these and other
examples, the importance of diversity and plasticity in antigen
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processing is clear and is also an attractive target for therapeu-
tic immunomodulation. Going forward though, as modulating
antigen processing continues to be investigated, more comprehen-
sive means of directly measuring their influence on the repertoire
of peptides presented as well as the epitope usage by T cells are
needed.
TOWARD COMPREHENSIVE ASSESSMENT OF EPITOPES
AND THEIR USAGE BY T CELLS
One of the most profound conundrums of T cell immunology
is the unpredictability of epitope use and what factors govern T
cell epitope dominance (14). Although clearly not the only factor,
one major contributor to the unpredictability of T cell epitope
usage comes from the complexities in antigen processing and pre-
sentation, as described above. To address the relationship between
antigen presentation and the antigen-specific T cell response, com-
prehensive methods for evaluating the identities and densities of
peptides presented by APC have proven very useful. Much progress
has been made since the first peptides were eluted from MHC,
fractionated, and sequenced using Edman degradation (15, 16).
Although difficult due to the very low abundance of any given
peptide antigen species, much progress has come through the
use of proteomic analysis of peptides eluted from MHC using
mass spectrometry (17). With these methods, unbiased catalogs of
endogenously processed and MHC class I or class II presented pep-
tides can be obtained and number in the hundreds to thousands
(17–19). However, caveats to this approach remain, including the
very large number of cells required for analysis and a bias against
low abundance and low affinity peptide ligands. In terms of sen-
sitivity for rare peptide antigens and the requirements of very
large numbers of input cells, progress can be expected from the
rapidly advancing sensitivity of highly sophisticated mass spec-
trometers (20). Already though, this approach is being widely
used. In particular, after early success in identifying melanoma
tumor antigens (21), it is now playing a central role in an over-
all strategy for identification and validation of tumor associated
T cell antigens (22). Advancements in methods of quantifying
peptide abundances are allowing for accurately comparing reper-
toires of peptides presented by different cell types or changes
induced by cytokine stimulation (23, 24). In conjunction with
transcriptional profiling, it has also used to assess factors that con-
tribute to changes in the repertoire of peptides presented by MHC.
Through these studies, the repertoire of peptides presented by
MHC is being found to be indicative of an integration of cellular
processes influenced by the transcriptome, the metabolic status
of the cell, and undoubtedly many other factors (25, 26). The
concept of the repertoire of peptides presented by MHC as an
integrative representation of cellular physiology is appealing and
it is not surprising given the complexity and plasticity of anti-
gen processing mechanisms. Another recent study used a targeted
and quantitative approach to measure the levels of presentation
of pre-identified peptides over the course of Vaccinia viral infec-
tion. This study found dramatic variation in peptide presentation
levels over the course of infection – again indicative of the plas-
ticity of antigen processing mechanisms. They also observed a
strikingly unpredictable relationship between the levels of peptide
being presented and the magnitude of the corresponding T cell
response (27). Thus, through further application of proteomics-
based assessment of antigen presentation, we can expect to learn
a great deal about the effects of the various modes of process-
ing and presentation. The index of antigens identified by these
approaches can also be used for subsequent analysis of T cell
responses.
In the past the only available approaches for tracking the
antigen-specific T cell response were indirect and relied on
response to antigen stimulation. More recently, the use of mul-
timeric peptide-MHC complexes allow for direct detection of
antigen-specific cells and accurate quantification regardless of T
cell functional capacity (28). Despite some remaining limitations
such as the relatively limited number of MHC alleles available
for investigation and the dependence on relatively high-affinity
T cell responses, recent progress has made the use of peptide-
MHC multimers making their use more attractive for the broad
analysis of antigen-specific T cell responses (29). In particular, the
development of mass cytometry, a mass spectrometry based flow
cytometry approach that uses heavy-metal tags instead of fluo-
rophores (30), has greatly enhanced the utility of this approach.
Although mass cytometry is still in its infancy and several limita-
tions exist such as slower cellular throughput, reduced sensitivity,
and an inability to sort or retain the cells being analyzed, the ben-
efits of additional analysis parameters, especially when applied
to multiplexing approaches are clear. Simultaneous assessment of
many more characteristics of the antigen-specific cells identified
with peptide-MHC multimers allows for a more comprehensive
assessment of the phenotypic and functional characteristics of the
antigen-specific T cells being identified (31). Also, through the use
of multiple heavy-metal tags per peptide-MHC tetramer species as
a part of a highly multiplexed assay, we recently demonstrated the
assessment of more than 100 different T cell antigen-specificities in
a single sample (see Figure 1) (32). In this study, the approach was
used to screen for T cell reactivity of a large number of MHC class I
binding peptides identified by binding prediction algorithms. The
phenotypes of cells specific for each of the peptides were assessed in
parallel and highlighted the remarkable influence of epitope usage
on the phenotypes of the responding cells even for cells target-
ing different part of the same viral pathogens. For instance, in the
case of EBV-specific cells consistent differences in phenotype were
observed for cells targeting latency-associated proteins compared
to lytic-cycle associated proteins. Similarly, we observed strikingly
different phenotypes, trafficking patterns, and tissue residence for
T cells specific for different parts of rotavirus in normal human
donors.
Aside from previously characterized epitopes and predicted
MHC-binding peptides, this highly multiplexed approach for
identifying and characterizing antigen-specific T cells should also
be useful for the screening of both MHC class I and class II lig-
ands identified by proteomics for the purposes of investigating
the consequences of variable antigen processing and presentation
pathways discussed here. With room for improvement through
dedication of additional parameters to multiplexed peptide-MHC
tetramer analysis, already the number of candidate epitopes that
can be screened is similar in scale to the number of peptides usu-
ally identified by mass spectrometry of MHC eluted peptides.
Through improved sensitivity of proteomics-based methods of
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FIGURE 1 | Multiplex analysis of antigen-specific T cells with mass
cytometry based combinatorial tetramer staining. 1. Starting with a
single blood or tissue sample, lymphocytes can be simultaneously
stained with over 100 different combinatorially encoded heavy-metal
labeled peptide-MHC tetramers. 2. To do this, tetramers are mixed into a
single cocktail prior to cell staining. 3. The same cells are also stained
with a cocktail of heavy-metal labeled antibodies for the purposes of
probing the phenotypic and functional characteristics of the
antigen-specific cells identified. 4. Prior to mass cytometry analysis, the
cells are fixed, stained with metal-labled DNA interchelator, washed, and
resuspended in water. 5. As they are introduced to the CyTOF® mass
cytometer, the cells are sprayed through a nebulizer and dried in argon
before being ionized in plasma. Time-of-flight mass spectrometry is used
to quantify each of the elemental tags on each cell. 6. Identities of
antigen-specific cells are determined using multidimensional
deconvolution algorithms and the phenotypic and functional
characteristics of these cells can be compared through various analysis
methods such as the clustergram shown.
peptide identification and extension of the multiplexing capac-
ity of the T cell analysis approach, it is hopeful that the goal
of a truly comprehensive means of assessing epitope usage by
antigen-specific T cells will be possible.
CONCLUDING REMARKS
In line with the theme of this Frontiers in Immunology topic, the
relationship between the complexities of antigen processing and
presentation and the consequential antigen-specific T cell response
were discussed. A great deal of successful research has led to under-
standing of the mechanisms, pathways, and molecular players of
antigen processing and presentation, holding promise for power-
ful new ways of modulating the T cell mediated immune response.
Nonetheless, due to the diversity of pathways and complexity of
modulators involved, it is not yet simple to predict how pertur-
bations will influence the repertoire of presented antigens or the
resulting T cell response. Thus, the use of proteomics-based iden-
tification of peptide-MHC ligands as well as multiplexed methods
for analyzing antigen-specific T cell responses should be useful for
future studies on this topic.
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